nodes	percent_of_prediction	percent_of_DWPC	metapath
Arsenic trioxide—ABCB1—Topotecan—cervical cancer	0.133	0.625	CbGbCtD
Arsenic trioxide—CYP3A4—Topotecan—cervical cancer	0.0798	0.375	CbGbCtD
Arsenic trioxide—CCND1—exocrine gland—cervical cancer	0.0124	0.0397	CbGeAlD
Arsenic trioxide—TXNRD1—Irinotecan—Topotecan—cervical cancer	0.0118	1	CbGdCrCtD
Arsenic trioxide—MAPK3—exocrine gland—cervical cancer	0.00927	0.0296	CbGeAlD
Arsenic trioxide—AKT1—exocrine gland—cervical cancer	0.00874	0.0279	CbGeAlD
Arsenic trioxide—JUN—exocrine gland—cervical cancer	0.00761	0.0243	CbGeAlD
Arsenic trioxide—CCND1—epithelium—cervical cancer	0.00541	0.0173	CbGeAlD
Arsenic trioxide—CCND1—uterine cervix—cervical cancer	0.00536	0.0171	CbGeAlD
Arsenic trioxide—CCND1—decidua—cervical cancer	0.00511	0.0163	CbGeAlD
Arsenic trioxide—CCND1—renal system—cervical cancer	0.00501	0.016	CbGeAlD
Arsenic trioxide—CCND1—endometrium—cervical cancer	0.00485	0.0155	CbGeAlD
Arsenic trioxide—CCND1—mammalian vulva—cervical cancer	0.00469	0.015	CbGeAlD
Arsenic trioxide—MAPK1—epithelium—cervical cancer	0.00456	0.0146	CbGeAlD
Arsenic trioxide—MAPK1—uterine cervix—cervical cancer	0.00452	0.0144	CbGeAlD
Arsenic trioxide—CCND1—uterus—cervical cancer	0.00447	0.0143	CbGeAlD
Arsenic trioxide—MAPK1—decidua—cervical cancer	0.0043	0.0138	CbGeAlD
Arsenic trioxide—TXNRD1—epithelium—cervical cancer	0.00424	0.0136	CbGeAlD
Arsenic trioxide—MAPK1—renal system—cervical cancer	0.00423	0.0135	CbGeAlD
Arsenic trioxide—TXNRD1—uterine cervix—cervical cancer	0.0042	0.0134	CbGeAlD
Arsenic trioxide—MAPK3—epithelium—cervical cancer	0.00403	0.0129	CbGeAlD
Arsenic trioxide—CCND1—female reproductive system—cervical cancer	0.00402	0.0128	CbGeAlD
Arsenic trioxide—TXNRD1—decidua—cervical cancer	0.00401	0.0128	CbGeAlD
Arsenic trioxide—MAPK3—uterine cervix—cervical cancer	0.004	0.0128	CbGeAlD
Arsenic trioxide—MAPK1—mammalian vulva—cervical cancer	0.00395	0.0126	CbGeAlD
Arsenic trioxide—TXNRD1—renal system—cervical cancer	0.00393	0.0126	CbGeAlD
Arsenic trioxide—MAPK3—decidua—cervical cancer	0.00381	0.0122	CbGeAlD
Arsenic trioxide—TXNRD1—endometrium—cervical cancer	0.0038	0.0122	CbGeAlD
Arsenic trioxide—AKT1—epithelium—cervical cancer	0.0038	0.0122	CbGeAlD
Arsenic trioxide—AKT1—uterine cervix—cervical cancer	0.00377	0.012	CbGeAlD
Arsenic trioxide—MAPK1—uterus—cervical cancer	0.00376	0.012	CbGeAlD
Arsenic trioxide—MAPK3—renal system—cervical cancer	0.00374	0.012	CbGeAlD
Arsenic trioxide—TXNRD1—mammalian vulva—cervical cancer	0.00368	0.0118	CbGeAlD
Arsenic trioxide—CCND1—female gonad—cervical cancer	0.00365	0.0117	CbGeAlD
Arsenic trioxide—CCND1—vagina—cervical cancer	0.00363	0.0116	CbGeAlD
Arsenic trioxide—MAPK3—endometrium—cervical cancer	0.00362	0.0116	CbGeAlD
Arsenic trioxide—AKT1—decidua—cervical cancer	0.00359	0.0115	CbGeAlD
Arsenic trioxide—AKT1—renal system—cervical cancer	0.00353	0.0113	CbGeAlD
Arsenic trioxide—TXNRD1—uterus—cervical cancer	0.0035	0.0112	CbGeAlD
Arsenic trioxide—MAPK3—mammalian vulva—cervical cancer	0.0035	0.0112	CbGeAlD
Arsenic trioxide—AKT1—endometrium—cervical cancer	0.00341	0.0109	CbGeAlD
Arsenic trioxide—MAPK1—female reproductive system—cervical cancer	0.00338	0.0108	CbGeAlD
Arsenic trioxide—MAPK3—uterus—cervical cancer	0.00333	0.0106	CbGeAlD
Arsenic trioxide—JUN—epithelium—cervical cancer	0.00331	0.0106	CbGeAlD
Arsenic trioxide—AKT1—mammalian vulva—cervical cancer	0.0033	0.0105	CbGeAlD
Arsenic trioxide—JUN—uterine cervix—cervical cancer	0.00328	0.0105	CbGeAlD
Arsenic trioxide—IKBKB—uterine cervix—cervical cancer	0.00327	0.0104	CbGeAlD
Arsenic trioxide—TXNRD1—female reproductive system—cervical cancer	0.00315	0.0101	CbGeAlD
Arsenic trioxide—AKT1—uterus—cervical cancer	0.00314	0.01	CbGeAlD
Arsenic trioxide—JUN—decidua—cervical cancer	0.00313	0.00999	CbGeAlD
Arsenic trioxide—IKBKB—decidua—cervical cancer	0.00311	0.00994	CbGeAlD
Arsenic trioxide—MAPK1—female gonad—cervical cancer	0.00308	0.00984	CbGeAlD
Arsenic trioxide—JUN—renal system—cervical cancer	0.00307	0.00981	CbGeAlD
Arsenic trioxide—MAPK1—vagina—cervical cancer	0.00306	0.00978	CbGeAlD
Arsenic trioxide—MAPK3—female reproductive system—cervical cancer	0.003	0.00957	CbGeAlD
Arsenic trioxide—JUN—endometrium—cervical cancer	0.00297	0.00948	CbGeAlD
Arsenic trioxide—IKBKB—endometrium—cervical cancer	0.00295	0.00944	CbGeAlD
Arsenic trioxide—JUN—mammalian vulva—cervical cancer	0.00287	0.00917	CbGeAlD
Arsenic trioxide—TXNRD1—female gonad—cervical cancer	0.00287	0.00916	CbGeAlD
Arsenic trioxide—IKBKB—mammalian vulva—cervical cancer	0.00286	0.00913	CbGeAlD
Arsenic trioxide—TXNRD1—vagina—cervical cancer	0.00285	0.0091	CbGeAlD
Arsenic trioxide—AKT1—female reproductive system—cervical cancer	0.00282	0.00903	CbGeAlD
Arsenic trioxide—JUN—uterus—cervical cancer	0.00273	0.00874	CbGeAlD
Arsenic trioxide—MAPK3—female gonad—cervical cancer	0.00273	0.00871	CbGeAlD
Arsenic trioxide—IKBKB—uterus—cervical cancer	0.00272	0.0087	CbGeAlD
Arsenic trioxide—MAPK3—vagina—cervical cancer	0.00271	0.00866	CbGeAlD
Arsenic trioxide—AKT1—female gonad—cervical cancer	0.00257	0.00821	CbGeAlD
Arsenic trioxide—AKT1—vagina—cervical cancer	0.00255	0.00816	CbGeAlD
Arsenic trioxide—JUN—female reproductive system—cervical cancer	0.00246	0.00786	CbGeAlD
Arsenic trioxide—IKBKB—female reproductive system—cervical cancer	0.00245	0.00782	CbGeAlD
Arsenic trioxide—CCND1—lymph node—cervical cancer	0.00235	0.00751	CbGeAlD
Arsenic trioxide—JUN—female gonad—cervical cancer	0.00224	0.00715	CbGeAlD
Arsenic trioxide—IKBKB—female gonad—cervical cancer	0.00223	0.00711	CbGeAlD
Arsenic trioxide—JUN—vagina—cervical cancer	0.00222	0.00711	CbGeAlD
Arsenic trioxide—IKBKB—vagina—cervical cancer	0.00221	0.00707	CbGeAlD
Arsenic trioxide—MAPK1—lymph node—cervical cancer	0.00198	0.00633	CbGeAlD
Arsenic trioxide—TXNRD1—lymph node—cervical cancer	0.00184	0.00589	CbGeAlD
Arsenic trioxide—MAPK3—lymph node—cervical cancer	0.00175	0.0056	CbGeAlD
Arsenic trioxide—ABCC2—renal system—cervical cancer	0.00167	0.00534	CbGeAlD
Arsenic trioxide—CYP1B1—decidua—cervical cancer	0.00167	0.00533	CbGeAlD
Arsenic trioxide—AKT1—lymph node—cervical cancer	0.00165	0.00528	CbGeAlD
Arsenic trioxide—CYP1B1—renal system—cervical cancer	0.00164	0.00523	CbGeAlD
Arsenic trioxide—CYP1B1—uterus—cervical cancer	0.00146	0.00466	CbGeAlD
Arsenic trioxide—JUN—lymph node—cervical cancer	0.00144	0.0046	CbGeAlD
Arsenic trioxide—IKBKB—lymph node—cervical cancer	0.00143	0.00457	CbGeAlD
Arsenic trioxide—ABCC2—female reproductive system—cervical cancer	0.00134	0.00428	CbGeAlD
Arsenic trioxide—CYP1B1—female reproductive system—cervical cancer	0.00131	0.00419	CbGeAlD
Arsenic trioxide—CYP1A1—epithelium—cervical cancer	0.00125	0.00399	CbGeAlD
Arsenic trioxide—CYP1A1—uterine cervix—cervical cancer	0.00124	0.00395	CbGeAlD
Arsenic trioxide—CYP1B1—female gonad—cervical cancer	0.00119	0.00381	CbGeAlD
Arsenic trioxide—CYP1A1—renal system—cervical cancer	0.00116	0.0037	CbGeAlD
Arsenic trioxide—CYP1A1—mammalian vulva—cervical cancer	0.00108	0.00346	CbGeAlD
Arsenic trioxide—CYP1A1—uterus—cervical cancer	0.00103	0.00329	CbGeAlD
Arsenic trioxide—CYP1A1—female reproductive system—cervical cancer	0.000927	0.00296	CbGeAlD
Arsenic trioxide—CYP3A4—renal system—cervical cancer	0.000849	0.00271	CbGeAlD
Arsenic trioxide—CYP1A1—female gonad—cervical cancer	0.000843	0.00269	CbGeAlD
Arsenic trioxide—CYP1A1—vagina—cervical cancer	0.000838	0.00268	CbGeAlD
Arsenic trioxide—ABCC2—lymph node—cervical cancer	0.000783	0.0025	CbGeAlD
Arsenic trioxide—CYP1B1—lymph node—cervical cancer	0.000767	0.00245	CbGeAlD
Arsenic trioxide—CYP3A4—female reproductive system—cervical cancer	0.00068	0.00217	CbGeAlD
Arsenic trioxide—ABCB1—epithelium—cervical cancer	0.000648	0.00207	CbGeAlD
Arsenic trioxide—ABCB1—uterine cervix—cervical cancer	0.000642	0.00205	CbGeAlD
Arsenic trioxide—ABCB1—decidua—cervical cancer	0.000612	0.00196	CbGeAlD
Arsenic trioxide—ABCB1—renal system—cervical cancer	0.000601	0.00192	CbGeAlD
Arsenic trioxide—ABCB1—endometrium—cervical cancer	0.000581	0.00186	CbGeAlD
Arsenic trioxide—ABCB1—mammalian vulva—cervical cancer	0.000562	0.0018	CbGeAlD
Arsenic trioxide—CYP1A1—lymph node—cervical cancer	0.000542	0.00173	CbGeAlD
Arsenic trioxide—ABCB1—uterus—cervical cancer	0.000535	0.00171	CbGeAlD
Arsenic trioxide—ABCB1—female reproductive system—cervical cancer	0.000481	0.00154	CbGeAlD
Arsenic trioxide—ABCB1—female gonad—cervical cancer	0.000438	0.0014	CbGeAlD
Arsenic trioxide—ABCB1—vagina—cervical cancer	0.000435	0.00139	CbGeAlD
Arsenic trioxide—ABCB1—lymph node—cervical cancer	0.000282	0.0009	CbGeAlD
Arsenic trioxide—MAPK3—Cellular Senescence—TP53—cervical cancer	7.35e-05	0.000159	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—WNT2—cervical cancer	7.32e-05	0.000158	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cellular responses to stress—STAT3—cervical cancer	7.28e-05	0.000157	CbGpPWpGaD
Arsenic trioxide—IKBKB—MAPK Signaling Pathway—TP53—cervical cancer	7.26e-05	0.000157	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—AKAP13—cervical cancer	7.25e-05	0.000157	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—NOTCH1—cervical cancer	7.25e-05	0.000157	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—HLA-DPB1—cervical cancer	7.22e-05	0.000156	CbGpPWpGaD
Arsenic trioxide—MAPK3—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	7.2e-05	0.000156	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—FGFR3—cervical cancer	7.17e-05	0.000155	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—FGFR3—cervical cancer	7.09e-05	0.000153	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by NGF—STAT3—cervical cancer	7.04e-05	0.000152	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—WNT2—cervical cancer	7e-05	0.000151	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—HLA-DPB1—cervical cancer	7e-05	0.000151	CbGpPWpGaD
Arsenic trioxide—CCND1—Cell Cycle—TP53—cervical cancer	7e-05	0.000151	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cellular Senescence—TP53—cervical cancer	7e-05	0.000151	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—AKAP13—cervical cancer	6.96e-05	0.000151	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cytokine Signaling in Immune system—STAT3—cervical cancer	6.95e-05	0.00015	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cellular responses to stress—STAT3—cervical cancer	6.93e-05	0.00015	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	6.85e-05	0.000148	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by NGF—STAT3—cervical cancer	6.83e-05	0.000148	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—FGFR3—cervical cancer	6.82e-05	0.000147	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—AKAP13—cervical cancer	6.76e-05	0.000146	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—HLA-DPB1—cervical cancer	6.66e-05	0.000144	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cytokine Signaling in Immune system—STAT3—cervical cancer	6.61e-05	0.000143	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—TERT—cervical cancer	6.6e-05	0.000143	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—CASP8—cervical cancer	6.58e-05	0.000142	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—FGFR3—cervical cancer	6.52e-05	0.000141	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by NGF—STAT3—cervical cancer	6.5e-05	0.000141	CbGpPWpGaD
Arsenic trioxide—AKT1—Gene Expression—NOTCH2—cervical cancer	6.49e-05	0.00014	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—AKAP13—cervical cancer	6.43e-05	0.000139	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by NGF—EGFR—cervical cancer	6.4e-05	0.000138	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—HLA-DPB1—cervical cancer	6.37e-05	0.000138	CbGpPWpGaD
Arsenic trioxide—IKBKB—Cytokine Signaling in Immune system—STAT3—cervical cancer	6.32e-05	0.000137	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—CASP8—cervical cancer	6.32e-05	0.000137	CbGpPWpGaD
Arsenic trioxide—MAPK3—Gene Expression—NOTCH2—cervical cancer	6.29e-05	0.000136	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—FGFR3—cervical cancer	6.26e-05	0.000135	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—WNT5A—cervical cancer	6.26e-05	0.000135	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	6.26e-05	0.000135	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling by NGF—STAT3—cervical cancer	6.22e-05	0.000134	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by NGF—EGFR—cervical cancer	6.21e-05	0.000134	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—AKAP13—cervical cancer	6.15e-05	0.000133	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—CASP8—cervical cancer	6.13e-05	0.000133	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—FGFR3—cervical cancer	6.06e-05	0.000131	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—WNT5A—cervical cancer	6.01e-05	0.00013	CbGpPWpGaD
Arsenic trioxide—JUN—Cellular responses to stress—TP53—cervical cancer	5.96e-05	0.000129	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by NGF—EGFR—cervical cancer	5.91e-05	0.000128	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—HLA-DQB1—cervical cancer	5.86e-05	0.000127	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—WNT5A—cervical cancer	5.83e-05	0.000126	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—CASP8—cervical cancer	5.83e-05	0.000126	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—NOTCH1—cervical cancer	5.69e-05	0.000123	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling by NGF—EGFR—cervical cancer	5.65e-05	0.000122	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—HLA-DQB1—cervical cancer	5.63e-05	0.000122	CbGpPWpGaD
Arsenic trioxide—MAPK3—Axon guidance—EGFR—cervical cancer	5.62e-05	0.000121	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—CASP8—cervical cancer	5.58e-05	0.000121	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cellular responses to stress—TP53—cervical cancer	5.56e-05	0.00012	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—WNT5A—cervical cancer	5.55e-05	0.00012	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CD8A—cervical cancer	5.48e-05	0.000118	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—HLA-DQB1—cervical cancer	5.46e-05	0.000118	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—MTOR—cervical cancer	5.41e-05	0.000117	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—CD4—cervical cancer	5.4e-05	0.000117	CbGpPWpGaD
Arsenic trioxide—MAPK1—Axon guidance—EGFR—cervical cancer	5.35e-05	0.000116	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—WNT5A—cervical cancer	5.31e-05	0.000115	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cellular responses to stress—TP53—cervical cancer	5.29e-05	0.000114	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CD8A—cervical cancer	5.26e-05	0.000114	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—CTNNB1—cervical cancer	5.22e-05	0.000113	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—HLA-DQB1—cervical cancer	5.2e-05	0.000112	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—MTOR—cervical cancer	5.2e-05	0.000112	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—CD4—cervical cancer	5.19e-05	0.000112	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CD8A—cervical cancer	5.1e-05	0.00011	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—CTNNB1—cervical cancer	5.06e-05	0.000109	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—MTOR—cervical cancer	5.04e-05	0.000109	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—CD4—cervical cancer	5.03e-05	0.000109	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—MTOR—cervical cancer	4.99e-05	0.000108	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—CD4—cervical cancer	4.98e-05	0.000108	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—HLA-DQB1—cervical cancer	4.97e-05	0.000108	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—HES1—cervical cancer	4.94e-05	0.000107	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CD8A—cervical cancer	4.86e-05	0.000105	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—CTNNB1—cervical cancer	4.82e-05	0.000104	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—MTOR—cervical cancer	4.8e-05	0.000104	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—CTNNB1—cervical cancer	4.8e-05	0.000104	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—HES1—cervical cancer	4.79e-05	0.000104	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—CD4—cervical cancer	4.79e-05	0.000104	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	4.73e-05	0.000102	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CD8A—cervical cancer	4.65e-05	0.0001	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—CTNNB1—cervical cancer	4.61e-05	9.96e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—MTOR—cervical cancer	4.59e-05	9.92e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CA9—cervical cancer	4.59e-05	9.92e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—CD4—cervical cancer	4.58e-05	9.91e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	4.56e-05	9.87e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—HES1—cervical cancer	4.56e-05	9.86e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—STAT3—cervical cancer	4.55e-05	9.84e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—FGFR3—cervical cancer	4.48e-05	9.69e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—CTNNB1—cervical cancer	4.47e-05	9.66e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—STAT3—cervical cancer	4.41e-05	9.54e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—MTOR—cervical cancer	4.41e-05	9.53e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—CD4—cervical cancer	4.4e-05	9.51e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—NOTCH2—cervical cancer	4.39e-05	9.5e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—MTHFR—cervical cancer	4.34e-05	9.39e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—TERT—cervical cancer	4.33e-05	9.36e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—FGFR3—cervical cancer	4.3e-05	9.31e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—MTOR—cervical cancer	4.26e-05	9.22e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—CTNNB1—cervical cancer	4.25e-05	9.2e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—NOTCH2—cervical cancer	4.22e-05	9.13e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—MTHFR—cervical cancer	4.21e-05	9.11e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—TERT—cervical cancer	4.2e-05	9.08e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—STAT3—cervical cancer	4.2e-05	9.08e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—FGFR3—cervical cancer	4.17e-05	9.03e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—EGFR—cervical cancer	4.13e-05	8.94e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—NOTCH2—cervical cancer	4.09e-05	8.85e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—CTNNB1—cervical cancer	4.07e-05	8.8e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Gene Expression—NOTCH1—cervical cancer	4.02e-05	8.69e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—EGFR—cervical cancer	4.01e-05	8.67e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—MTHFR—cervical cancer	4.01e-05	8.66e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—TERT—cervical cancer	4e-05	8.64e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—FGFR3—cervical cancer	3.97e-05	8.59e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—FGFR3—cervical cancer	3.97e-05	8.59e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—CASP3—cervical cancer	3.92e-05	8.48e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Gene Expression—NOTCH1—cervical cancer	3.9e-05	8.43e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—NOTCH2—cervical cancer	3.89e-05	8.42e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—FGFR3—cervical cancer	3.85e-05	8.33e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CASP8—cervical cancer	3.83e-05	8.28e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—EGFR—cervical cancer	3.81e-05	8.25e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—EGFR—cervical cancer	3.8e-05	8.22e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—FGFR3—cervical cancer	3.8e-05	8.22e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—CTNNB1—cervical cancer	3.78e-05	8.17e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—NOTCH1—cervical cancer	3.73e-05	8.07e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—NOTCH2—cervical cancer	3.73e-05	8.06e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CASP8—cervical cancer	3.68e-05	7.96e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—FGFR3—cervical cancer	3.67e-05	7.93e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CA9—cervical cancer	3.66e-05	7.92e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—EGFR—cervical cancer	3.65e-05	7.89e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—MTHFR—cervical cancer	3.64e-05	7.86e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—NOTCH1—cervical cancer	3.62e-05	7.82e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	3.61e-05	7.82e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—HES1—cervical cancer	3.6e-05	7.79e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CASP8—cervical cancer	3.57e-05	7.72e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—EGFR—cervical cancer	3.54e-05	7.66e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—EGFR—cervical cancer	3.51e-05	7.58e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—HES1—cervical cancer	3.46e-05	7.48e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—NOTCH1—cervical cancer	3.44e-05	7.44e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—TP53—cervical cancer	3.4e-05	7.36e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CASP8—cervical cancer	3.4e-05	7.34e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—EGFR—cervical cancer	3.37e-05	7.29e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—HES1—cervical cancer	3.36e-05	7.26e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—TP53—cervical cancer	3.3e-05	7.14e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—STAT3—cervical cancer	3.29e-05	7.12e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CASP8—cervical cancer	3.25e-05	7.03e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—EGFR—cervical cancer	3.22e-05	6.97e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—HES1—cervical cancer	3.19e-05	6.9e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—TERT—cervical cancer	3.16e-05	6.82e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—MTOR—cervical cancer	3.15e-05	6.81e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CD4—cervical cancer	3.15e-05	6.8e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—TP53—cervical cancer	3.14e-05	6.79e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cell Cycle—TP53—cervical cancer	3.12e-05	6.74e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—EGFR—cervical cancer	3.1e-05	6.69e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—HES1—cervical cancer	3.05e-05	6.61e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	3.04e-05	6.56e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—TERT—cervical cancer	3.03e-05	6.56e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—MTOR—cervical cancer	3.03e-05	6.55e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—MTHFR—cervical cancer	3.02e-05	6.54e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CD4—cervical cancer	3.02e-05	6.53e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—EGFR—cervical cancer	2.99e-05	6.47e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cell Cycle—TP53—cervical cancer	2.97e-05	6.41e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—TERT—cervical cancer	2.94e-05	6.36e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—MTOR—cervical cancer	2.94e-05	6.35e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CD4—cervical cancer	2.93e-05	6.34e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—FGFR3—cervical cancer	2.9e-05	6.26e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—TERT—cervical cancer	2.8e-05	6.05e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—MTOR—cervical cancer	2.79e-05	6.04e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—MTOR—cervical cancer	2.79e-05	6.04e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CTNNB1—cervical cancer	2.79e-05	6.04e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—CD4—cervical cancer	2.79e-05	6.03e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CD4—cervical cancer	2.79e-05	6.03e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—FGFR3—cervical cancer	2.78e-05	6.02e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—NOTCH1—cervical cancer	2.72e-05	5.88e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—MTOR—cervical cancer	2.71e-05	5.86e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—CD4—cervical cancer	2.71e-05	5.85e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—FGFR3—cervical cancer	2.7e-05	5.84e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CTNNB1—cervical cancer	2.68e-05	5.8e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—TERT—cervical cancer	2.68e-05	5.79e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—MTOR—cervical cancer	2.67e-05	5.78e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CD4—cervical cancer	2.67e-05	5.77e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—NOTCH1—cervical cancer	2.61e-05	5.65e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CTNNB1—cervical cancer	2.6e-05	5.63e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—MTOR—cervical cancer	2.58e-05	5.58e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—CD4—cervical cancer	2.57e-05	5.57e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—FGFR3—cervical cancer	2.57e-05	5.55e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—NOTCH1—cervical cancer	2.53e-05	5.48e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—TP53—cervical cancer	2.51e-05	5.44e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—CTNNB1—cervical cancer	2.48e-05	5.36e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CTNNB1—cervical cancer	2.48e-05	5.36e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—FGFR3—cervical cancer	2.46e-05	5.31e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—STAT3—cervical cancer	2.44e-05	5.27e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—NOTCH1—cervical cancer	2.41e-05	5.21e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—CTNNB1—cervical cancer	2.4e-05	5.2e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CTNNB1—cervical cancer	2.37e-05	5.12e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—STAT3—cervical cancer	2.34e-05	5.06e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—EGFR—cervical cancer	2.33e-05	5.03e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—NOTCH1—cervical cancer	2.31e-05	4.99e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—CTNNB1—cervical cancer	2.29e-05	4.95e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—STAT3—cervical cancer	2.27e-05	4.91e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—EGFR—cervical cancer	2.26e-05	4.88e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CA9—cervical cancer	2.26e-05	4.88e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—EGFR—cervical cancer	2.21e-05	4.79e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—STAT3—cervical cancer	2.16e-05	4.67e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—STAT3—cervical cancer	2.16e-05	4.67e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—EGFR—cervical cancer	2.15e-05	4.64e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—EGFR—cervical cancer	2.13e-05	4.6e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—STAT3—cervical cancer	2.09e-05	4.53e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—STAT3—cervical cancer	2.07e-05	4.47e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—EGFR—cervical cancer	2.06e-05	4.46e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—MTOR—cervical cancer	2.04e-05	4.41e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—STAT3—cervical cancer	1.99e-05	4.31e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—EGFR—cervical cancer	1.96e-05	4.25e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—EGFR—cervical cancer	1.96e-05	4.24e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—MTOR—cervical cancer	1.96e-05	4.23e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—EGFR—cervical cancer	1.9e-05	4.12e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—MTOR—cervical cancer	1.9e-05	4.11e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—EGFR—cervical cancer	1.88e-05	4.06e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CASP3—cervical cancer	1.87e-05	4.05e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—MTHFR—cervical cancer	1.86e-05	4.02e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—EGFR—cervical cancer	1.81e-05	3.92e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—MTOR—cervical cancer	1.81e-05	3.91e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CTNNB1—cervical cancer	1.81e-05	3.91e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CASP3—cervical cancer	1.8e-05	3.89e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CASP3—cervical cancer	1.75e-05	3.78e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CTNNB1—cervical cancer	1.74e-05	3.75e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—MTOR—cervical cancer	1.73e-05	3.74e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CTNNB1—cervical cancer	1.68e-05	3.64e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CASP3—cervical cancer	1.66e-05	3.59e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CTNNB1—cervical cancer	1.6e-05	3.46e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CASP3—cervical cancer	1.59e-05	3.44e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—STAT3—cervical cancer	1.57e-05	3.4e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CTNNB1—cervical cancer	1.53e-05	3.31e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—STAT3—cervical cancer	1.51e-05	3.27e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—MTHFR—cervical cancer	1.49e-05	3.21e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—STAT3—cervical cancer	1.47e-05	3.17e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—EGFR—cervical cancer	1.43e-05	3.09e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—STAT3—cervical cancer	1.4e-05	3.02e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—EGFR—cervical cancer	1.37e-05	2.97e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—STAT3—cervical cancer	1.34e-05	2.89e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—EGFR—cervical cancer	1.33e-05	2.88e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—EGFR—cervical cancer	1.27e-05	2.74e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—EGFR—cervical cancer	1.21e-05	2.62e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—TP53—cervical cancer	1.2e-05	2.6e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—TP53—cervical cancer	1.15e-05	2.5e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—TP53—cervical cancer	1.12e-05	2.42e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—TP53—cervical cancer	1.07e-05	2.3e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—TP53—cervical cancer	1.02e-05	2.2e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—MTHFR—cervical cancer	9.16e-06	1.98e-05	CbGpPWpGaD
